Beta Bionics, Inc. (BBNX)
16.92
+1.22
(+7.80%)
USD |
NASDAQ |
Nov 09, 16:00
16.92
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Debt to Equity Ratio : 0.0152 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0152 |
| June 30, 2026 | 0.0254 |
| March 31, 2026 | 0.0255 |
| December 31, 2025 | 0.0254 |
| September 30, 2025 | 0.0261 |
| June 30, 2025 | 0.0222 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.0222 |
| December 31, 2024 | 0.0954 |
| September 30, 2024 | 0.2221 |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 0.0721 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| PROCEPT BioRobotics Corp. | 0.2341 |
| Edwards Lifesciences Corp. | 0.0649 |
| Intuitive Surgical, Inc. | 0.00 |
| Stryker Corp. | 0.6579 |
| Zimmer Biomet Holdings, Inc. | 0.5902 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 443.76M |
| Total Liabilities (Quarterly) | 42.38M |
| Shareholders Equity (Quarterly) | 401.38M |
| Current Ratio | 8.922 |
| Net Debt Paydown Yield | 0.01% |